Exponent Q2 FY26 net income rises 11% to $29.4 million; revenue climbs 21% to $171.6 million
EXPO•Q2 FY26 results
Exponent posted Q2 FY2026 net income of USD 29.4 million, up from USD 26.6 million, with diluted EPS of USD 0.60 versus USD 0.52.
Revenue rose 21% to USD 171.6 million, driven by higher reimbursements; revenue before reimbursements grew 12% to USD 148.9 million.
Non-GAAP EBITDA increased to USD 42.7 million from USD 37.0 million; margin widened 0.9 percentage points to 28.7% of revenue before reimbursements.
Business trends and outlook
Management cited strong proactive demand for AI-related user research and utility-sector risk work, with reactive activity supported by dispute engagements.
Exponent raised FY2026 guidance, projecting revenue before reimbursements growth of 9% to 10% and EBITDA margin of 27.8% to 28.1%.
